Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SAB BIOTHERAPEUTICS INC
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-09-13
Purchase
2022-09-14
5:16 pm
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
10,000 $0.7297 $7,297 4,993,090
(Direct)
View
2022-09-07
Purchase
2022-09-08
4:31 pm
SAB Biotherapeutics Inc. SABS Sullivan Eddie Joe
CEO
10% Owner
14,000 $0.7368 $10,315 5,230,564
(Direct)
View
2021-10-18
Sale
2021-11-16
3:09 pm
SAB Biotherapeutics Inc. SABS Beyer Russell P
CFO
278 $7.9 $2,196 2,490
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-09-13
Option Award
2022-09-15
5:15 pm
N/A
2032-09-13
SAB Biotherapeutics Inc. SABS Reich Samuel J
Chairman
525,000 $0 525,000
(Direct)
View
2022-09-13
Option Award
2022-09-15
5:15 pm
N/A
2032-09-13
SAB Biotherapeutics Inc. SABS Sullivan Eddie Joe
CEO
10% Owner
35,000 $0 35,000
(Direct)
View
2022-09-13
Option Award
2022-09-15
5:00 pm
N/A
2032-09-13
SAB Biotherapeutics Inc. SABS Giberson Scott
Director
25,000 $0 25,000
(Direct)
View
2022-09-13
Option Award
2022-09-15
5:00 pm
N/A
2032-09-13
SAB Biotherapeutics Inc. SABS Kropotova Alexandra
Chief Medical Officer
18,325 $0 18,325
(Direct)
View
2022-09-13
Option Award
2022-09-15
4:45 pm
N/A
2032-09-13
SAB Biotherapeutics Inc. SABS Bausch Christoph Lawrence
CHIEF OPERATING OFFICER
274,875 $0 274,875
(Direct)
View
2022-09-13
Option Award
2022-09-15
4:45 pm
N/A
2032-09-13
SAB Biotherapeutics Inc. SABS Beyer Russell P
CFO
274,875 $0 274,875
(Direct)
View
2022-06-06
Option Award
2022-06-07
8:00 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Kropotova Alexandra
Chief Medical Officer
300,000 $0 300,000
(Direct)
View
2022-05-20
Other
2022-05-23
5:52 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Spragens Jeffrey G
Director
299,002 $0 611,004
(Direct)
View
2022-05-20
Other
2022-05-23
5:45 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Reich Samuel J
Chairman
2,707,128 $0 3,462,827
(Indirect)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2033-03-16
SAB Biotherapeutics Inc. SABS Sullivan Eddie Joe
CEO
10% Owner
21,218 $0 21,218
(Direct)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2032-03-16
SAB Biotherapeutics Inc. SABS Beyer Russell P
CFO
6,000 $0 6,000
(Direct)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2032-03-16
SAB Biotherapeutics Inc. SABS Luke Thomas Charles
Chief Medical Officer
20,519 $0 20,519
(Direct)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2032-03-16
SAB Biotherapeutics Inc. SABS Finnegan Frederick
Chief Business Officer
23,453 $0 23,453
(Direct)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2032-03-16
SAB Biotherapeutics Inc. SABS Reich Samuel J
Chairman
7,000 $0 7,000
(Direct)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2032-03-16
SAB Biotherapeutics Inc. SABS Ullerich Melissa Vera
Chief Communications Officer
16,405 $0 16,405
(Direct)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2032-03-16
SAB Biotherapeutics Inc. SABS Pommer Jerry Lynn
Chief Compliance Officer
15,172 $0 15,172
(Direct)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2032-03-16
SAB Biotherapeutics Inc. SABS Bausch Christoph Lawrence
Chief Science Officer
24,972 $0 24,972
(Direct)
View
2022-03-16
Option Award
2022-03-18
9:15 pm
N/A
2032-03-16
SAB Biotherapeutics Inc. SABS Erickson Bruce Kipp
Chief Operating Officer
18,196 $0 18,196
(Direct)
View
2021-10-22(A)
Option Award
2021-11-24
7:37 pm
N/A
2027-03-12
SAB Biotherapeutics Inc. SABS Bausch Christoph Lawrence
Chief Science Officer
294,200 $0 294,200
(Direct)
View
2021-10-22(A)
Option Award
2021-11-22
2:31 pm
N/A
2031-01-01
SAB Biotherapeutics Inc. SABS Polvino William James
Director
151,333 $0 151,333
(Direct)
View
2021-11-17
Option Award
2021-11-19
4:45 pm
N/A
2031-11-17
SAB Biotherapeutics Inc. SABS Beyer Russell P
CFO
110,000 $0 110,000
(Direct)
View
2021-11-17
Option Award
2021-11-19
4:05 pm
N/A
2031-11-17
SAB Biotherapeutics Inc. SABS Reich Samuel J
Chairman
350,000 $0 350,000
(Direct)
View
2021-10-18
Option Award
2021-11-16
3:09 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Beyer Russell P
CFO
159 $10.08 2,490
(Indirect)
View
2021-10-18
Option Award
2021-11-16
3:09 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Beyer Russell P
CFO
2,475 $10.1 2,490
(Direct)
View
2021-10-18
Option Award
2021-11-16
3:09 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Beyer Russell P
CFO
5 $10.07 2,490
(Indirect)
View
2021-10-18
Option Award
2021-11-16
3:09 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Beyer Russell P
CFO
129 $7.78 2,490
(Indirect)
View
2021-10-22
Option Award
2021-10-26
9:53 pm
N/A
2031-05-27
SAB Biotherapeutics Inc. SABS Carillo Carlos N
VP
17,681 $0 17,681
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:53 pm
N/A
2031-05-27
SAB Biotherapeutics Inc. SABS Erickson Bruce Kipp
Chief Operating Officer
232,642 $0 232,642
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:52 pm
N/A
2024-08-05
SAB Biotherapeutics Inc. SABS Wu Hua
VP
116,524 $0 116,524
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:52 pm
N/A
2031-01-01
SAB Biotherapeutics Inc. SABS Polvino William James
Director
151,333 $0 151,333
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Finnegan Frederick
Chief Business Officer
263,232 $0 263,232
(Direct)
View
2021-10-01
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Hamilton Edward D.
10% Owner
25,000 $10.08 9,967,964
(Indirect)
View
2021-10-01
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Hamilton Edward D.
10% Owner
28,587 $10.1 9,967,964
(Direct)
View
2021-10-01
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Hamilton Edward D.
10% Owner
25,000 $10.09 9,967,964
(Indirect)
View
2021-10-01
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Hamilton Edward D.
10% Owner
14,937,369 $0 9,967,964
(Direct)
View
2021-10-19
Option Award
2021-10-26
9:50 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Luke Thomas Charles
Chief Medical Officer
990 $10.1 219,930
(Direct)
View
2021-10-19
Option Award
2021-10-26
9:50 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Luke Thomas Charles
Chief Medical Officer
219,930 $0 219,930
(Direct)
View
2021-10-07
Option Award
2021-10-26
9:50 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Sullivan Eddie Joe
CEO
10% Owner
2,800 $10.07 2,795,084
(Direct)
View
2021-10-07
Option Award
2021-10-26
9:50 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Sullivan Eddie Joe
CEO
10% Owner
8,006,048 $0 2,795,084
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:49 pm
N/A
2031-01-01
SAB Biotherapeutics Inc. SABS Turner Mervyn
Director
79,192 $0 79,192
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:49 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Link David Charles
Director
149,483 $0 149,483
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:48 pm
N/A
2027-03-27
SAB Biotherapeutics Inc. SABS Bausch Christoph Lawrence
Chief Science Officer
375,625 $0 375,625
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:48 pm
N/A
2030-04-27
SAB Biotherapeutics Inc. SABS Ullerich Melissa Vera
Chief Communications Officer
220,817 $0 220,817
(Direct)
View
2021-10-01
Option Award
2021-10-26
9:48 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
25,000 $10.08 9,913,018
(Indirect)
View
2021-10-01
Option Award
2021-10-26
9:48 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
28,587 $10.1 9,913,018
(Indirect)
View
2021-10-01
Option Award
2021-10-26
9:48 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
25,000 $10.09 9,913,018
(Direct)
View
2021-10-01
Option Award
2021-10-26
9:48 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
14,937,369 $0 9,913,018
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next